IDENIX PHARMACEUTICALS INC
IDIX
IDIX was delisted on the 5th of August, 2014.
0 hedge funds and large institutions have $0 invested in IDENIX PHARMACEUTICALS INC in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 130 closing their positions.
100% less funds holding
Funds holding: 131 → 0 (-131)
100% less funds holding in top 10
Funds holding in top 10: 6 → 0 (-6)
100% less capital invested
Capital invested by funds: $2.78B → $0 (-$2.78B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 130
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$1.27B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$173M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$123M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$106M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$88.2M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LTFS
126
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$24K | -1,000 | Closed |
|
127
Ameriprise
Minneapolis,
Minnesota
| – | -$17K | -721 | Closed |
|
128
Creative Planning
Overland Park,
Kansas
| – | -$12K | -500 | Closed |
|
129
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$9K | -356 | Closed |
|
|
TRCT
130
Tower Research Capital (TRC)
New York
| – | -$1K | -60 | Closed |
|
IDIX Hedge Fund Activity: Q3 2014 in Review
0 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in IDENIX PHARMACEUTICALS INC (IDIX) for Q3 2014, worth a combined $0 — down 100% from $2.78B a quarter earlier.
Sellers outnumbered buyers: 130 funds closed out of IDIX and 0 opened new positions — a net loss of 130 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Baupost Group, exiting entirely with an estimated $1.27B sold.
- 0 institutional investors held IDENIX PHARMACEUTICALS INC (IDIX) as of Q3 2014, down from 131 in Q2 2014.
- Funds reported $0 of IDENIX PHARMACEUTICALS INC stock for Q3 2014, down 100% quarter-over-quarter.
- 0 funds opened new IDENIX PHARMACEUTICALS INC positions in Q3 2014 and 130 closed out, a net change of -130 holders.
- The largest IDENIX PHARMACEUTICALS INC seller in Q3 2014 was Baupost Group, an estimated $1.27B sold.
Based on aggregated 13F filings for Q3 2014.